Google Alert - in

	in As-it-happens update ⋅ 25 July 2024
	WEB
	Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women The New England Journal of Medicine There are gaps in uptake of, adherence to, and persistence in the use of preexposure prophylaxis for human immunodeficiency virus (HIV) prevention ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis